Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea

Health Canada carried out a safety review to look into the risk of sleep apnoea with the use of atypical antipsychotics. Sleep apnoea is a disorder that causes breaks in breathing or shallow breaths during sleep. This review was triggered by the submission of new safety information from the manufacturer of quetiapine (Seroquel) that included cases of sleep apnoea in patients using quetiapine.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-05-08

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data